201 related articles for article (PubMed ID: 26411359)
1. Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function.
Michelucci A; D'Elios MM; Sticchi E; Pieragnoli P; Ricciardi G; Fatini C; Benagiano M; Niccolai E; Grassi A; Attanà P; Nesti M; Grifoni G; Padeletti L; Abbate R; Prisco D
Pacing Clin Electrophysiol; 2016 Jan; 39(1):65-72. PubMed ID: 26411359
[TBL] [Abstract][Full Text] [Related]
2. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
[TBL] [Abstract][Full Text] [Related]
4. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
[TBL] [Abstract][Full Text] [Related]
6. A metric for evaluating the cardiac response to resynchronization therapy.
Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
Chatterjee NA; Singh JP; Szymonifka J; Deaño RC; Thai WE; Wai B; Min JK; Januzzi JL; Truong QA
Int J Cardiol; 2016 Feb; 205():43-49. PubMed ID: 26710332
[TBL] [Abstract][Full Text] [Related]
8. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
Singal G; Upadhyay GA; Borgquist R; Friedman DJ; Chatterjee NA; Kandala J; Park MY; Orencole M; Dec GW; Picard MH; Singh JP; Mela T
Pacing Clin Electrophysiol; 2015 Oct; 38(10):1192-200. PubMed ID: 26179289
[TBL] [Abstract][Full Text] [Related]
9. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
10. Can Pulmonary Vascular Resistance Predict Response to Cardiac Resynchronization Therapy in Patients with Heart Failure?
Xu Z; Zhang H; Pan C; Zhang J; Hu Z
Pacing Clin Electrophysiol; 2015 Oct; 38(10):1210-6. PubMed ID: 26172993
[TBL] [Abstract][Full Text] [Related]
11. Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT).
Goldenberg I; Moss AJ; McNitt S; Barsheshet A; Gray D; Andrews ML; Brown MW; Zareba W; Sze E; Solomon SD; Pfeffer MA;
Heart Rhythm; 2010 Dec; 7(12):1777-82. PubMed ID: 20833266
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging assessment of intraventricular dyssynchrony and delayed enhancement as predictors of response to cardiac resynchronization therapy in patients with heart failure of ischaemic and non-ischaemic etiologies.
Petryka J; Miśko J; Przybylski A; Śpiewak M; Małek ŁA; Werys K; Mazurkiewicz Ł; Gepner K; Croisille P; Demkow M; Rużyłło W
Eur J Radiol; 2012 Oct; 81(10):2639-47. PubMed ID: 22056486
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β
Nagatomo Y; McNamara DM; Alexis JD; Cooper LT; Dec GW; Pauly DF; Sheppard R; Starling RC; Tang WH;
J Am Coll Cardiol; 2017 Feb; 69(8):968-977. PubMed ID: 28231950
[TBL] [Abstract][Full Text] [Related]
14. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
[TBL] [Abstract][Full Text] [Related]
15. Remote past left ventricular function before chronic right ventricular pacing predicts responses to cardiac resynchronization therapy upgrade.
Chang PC; Wo HT; Chen TH; Wu D; Lin FC; Wang CC
Pacing Clin Electrophysiol; 2014 Apr; 37(4):454-63. PubMed ID: 24251726
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
17. Relationship between two-dimensional speckle-tracking septal strain and response to cardiac resynchronization therapy in patients with left ventricular dysfunction and left bundle branch block: a prospective pilot study.
Maréchaux S; Guiot A; Castel AL; Guyomar Y; Semichon M; Delelis F; Heuls S; Ennezat PV; Graux P; Tribouilloy C
J Am Soc Echocardiogr; 2014 May; 27(5):501-11. PubMed ID: 24513239
[TBL] [Abstract][Full Text] [Related]
18. Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Stolen CM; Adourian A; Meyer TE; Stein KM; Solomon SD
J Card Fail; 2014 Nov; 20(11):793-9. PubMed ID: 25106783
[TBL] [Abstract][Full Text] [Related]
19. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
[TBL] [Abstract][Full Text] [Related]
20. β2-adrenergic receptor autoantibodies alleviated myocardial damage induced by β1-adrenergic receptor autoantibodies in heart failure.
Cao N; Chen H; Bai Y; Yang X; Xu W; Hao W; Zhou Y; Chai J; Wu Y; Wang Z; Yin X; Wang L; Wang W; Liu H; Fu MLX
Cardiovasc Res; 2018 Sep; 114(11):1487-1498. PubMed ID: 29746700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
